SCNN1A Gene

SCNN1A Gene

Overview

SCNN1A Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SCNN1A Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SCNN1A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Sodium Channel Epithelial Subunit Alpha</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12p13.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6337</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>600228</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000111319</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P37088</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>ENaC alpha subunit (Alpha-ENaC)</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">alpha (alpha)</td>
<td>SCNN1A</td>
</tr>
<tr>
<td class="label">beta (beta)</td>
<td>SCNN1B</td>
</tr>
<tr>
<td class="label">gamma (gamma)</td>
<td>SCNN1G</td>
</tr>
<tr>
<td class="label">delta (delta)</td>
<td>SCNN1D</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Kidney collecting duct</td>
<td>Regulates Na+ reabsorption, blood pressure</td>
</tr>
<tr>
<td class="label">Lung alveolar epithelium</td>
<td>Maintains alveolar fluid clearance</td>
</tr>
<tr>
<td class="label">Distal colon</td>
<td>Na+ absorption from diet</td>
</tr>
<tr>
<td class="label">Salivary glands</td>
<td>Saliva formation</td>
</tr>
<tr>
<td class="label">Sweat glands</td>
<td>Sweat production</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Amiloride</td>
<td>Direct ENaC blocker</td>
</tr>
<tr>
<td class="label">Benzamil</td>
<td>Potent ENaC blocker</td>
</tr>
<tr>
<td class="label">Triamterene</td>
<td>Potassium-sparing diuretic</td>
</tr>
<tr>
<td class="label">Spironolactone</td>
<td>Aldosterone antagonist</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Sensory neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hypothalamic neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cortical neurons</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Endothelial cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">91 edges</a></td>
</tr>
</table>

SCNN1A (Sodium Channel Epithelial Subunit Alpha) encodes the alpha-subunit of the epithelial sodium channel (ENaC), also known as the amiloride-sensitive sodium channel. Originally characterized in kidney and lung epithelia, ENaC is now recognized as playing important roles in the central nervous system, including neuronal excitability, salt taste perception, and possibly neurodegenerative processes["@hummler2017"].

Protein Structure and Function

Channel Architecture

ENaC is a heterotrimeric channel composed of three distinct subunits:

Each subunit contains:

• Two transmembrane domains: Form the channel pore
• Large extracellular loop: Contains the amiloride-binding site
• N-terminal and C-terminal cytoplasmic domains: Regulate channel activity

Gating and Regulation

ENaC exhibits characteristic features:

• Amiloride sensitivity: Blocked by low concentrations of amiloride (IC50 ~100 nM)
• Na+ selectivity: Highly selective for Na+ over K+ (selectivity ratio >100:1)
• Slow gating: Transitions between open and closed states over seconds
• Self-inhibition: Extracellular Na+ inhibits channel activity (feedback regulation)

Normal Physiological Functions

Peripheral Functions

In non-neuronal tissues, ENaC is critical for:

Central Nervous System Functions

Within the brain and sensory systems[@giraldez2015]:

Neuronal Expression:

• Dorsal root ganglion (sensory neurons)
• Hypothalamic nuclei (osmoreception, salt appetite)
• Cerebral cortex
• [Cerebellum](/brain-regions/cerebellum)
• [Hippocampus](/brain-regions/hippocampus)

• Mechanosensation: ENaC contributes to touch and pressure sensing
• Salt taste perception: Essential for detecting NaCl in taste buds
• Osmoreception: Hypothalamic neurons sense serum osmolality
• Neuronal excitability: Modulates firing properties

Role in Neurodegenerative Diseases

Alzheimer's Disease

Emerging evidence suggests ENaC involvement in AD pathogenesis[@schild2020]:

Mechanisms:

• Amyloid-β interaction: Aβ may directly modulate ENaC activity
• Sodium dysregulation: Altered neuronal Na+ handling in AD
• Blood-brain barrier: ENaC in brain endothelial cells may affect BBB integrity

• ENaC expression is altered in AD brain tissue
• Amiloride has shown protective effects in AD models
• Sodium dysregulation is a known feature of AD

Parkinson's Disease

ENaC may contribute to dopaminergic neuron function[@yang2022]:

• Expressed in substantia nigra neurons
• May modulate neuronal excitability
• Altered expression in PD models
• Potential role in neuroinflammation

Epilepsy

Ion channel dysfunction contributes to seizure disorders[@elhashash2020]:

• ENaC variants associated with epilepsy risk
• Altered neuronal excitability with ENaC dysregulation
• Amiloride has anticonvulsant effects in some models

Stroke

SCNN1A variants influence stroke risk and outcomes[@starr2020]:

• ENaC in cerebral vasculature
• Blood pressure regulation affects stroke risk
• Neuroprotective potential of ENaC blockers

Clinical Significance

Liddle Syndrome

Gain-of-function mutations in SCNN1B or SCNN1G (not SCNN1A) cause Liddle syndrome:

• Early-onset hypertension
• Hypokalemia
• Metabolic alkalosis
• Suppressed plasma renin and aldosterone

Pseudohypoaldosteronism Type I (PHA1)

Loss-of-function mutations in any ENaC subunit cause PHA1:

• Severe salt-wasting
• Hyperkalemia
• Hypotension
• Elevated aldosterone levels

Bronchiolitis

• ENaC overactivity in airway epithelium
• Contributes to severe respiratory syncytial virus infection
• Amiloride has been used experimentally

Therapeutic Modulation

Pharmacological Agents

Drug Development

• Selective ENaC activators: For hypotension, cystic fibrosis
• Subunit-specific modulators: Tissue-selective targeting
• Novel amiloride analogs: Enhanced potency, reduced side effects[@rubenstein2021]

Expression Pattern

Brain Regions

SCNN1A is expressed in:

• Hypothalamic nuclei (paraventricular, supraoptic)
• Dorsal root ganglion
• Cerebral cortex (layers II-IV)
• Cerebellum (Purkinje cells, granule cells)
• Hippocampus (CA1-CA3)

Cell Type Specificity

Animal Models

Knockout Mice

• Scnn1a-/-: Neonatal lethality due to respiratory failure
• Conditional knockouts: Brain-specific deletion viable
• Phenotype: Altered sodium handling, blood pressure

Transgenic Models

• Human variants: Express disease-associated mutations
• Overexpression models: Study gain-of-function
• Reporter lines: Track ENaC expression

Research Methods

Electrophysiology

• Patch-clamp in Xenopus oocytes
• Whole-cell recording from neurons
• Noise analysis for single-channel properties

Molecular Biology

• siRNA knockdown
• CRISPR-Cas9 editing
• Immunoprecipitation

Imaging

• GFP-tagged constructs for trafficking
• Live-cell calcium imaging
• Regional expression mapping

Gene Variation

Pathogenic Variants

• Missense mutations in transmembrane domains
• Splice site mutations
• Nonsense mutations causing PHA1

Polymorphisms

• Population-specific variants
• Association with blood pressure
• Potential disease modifiers

See Also

• [SCNN1A Protein](/proteins/enac-alpha-protein)
• [Liddle Syndrome](/diseases/liddle-syndrome)
• [Ion Channel Disorders](/mechanisms/ion-channel-disorders)
• [Sodium Channels in Neurodegeneration](/mechanisms/sodium-channel-dysfunction)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving SCNN1A Gene discovered through SciDEX knowledge graph analysis: